MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
$28,870K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net income
    • Depreciation and amortization
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Repayment of debt
    • Changes in operating assets and ...
    • Change in fair value of continge...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
18,452
13,131
6,562
1,077
Depreciation and amortization
15,549
15,479
16,401
15,596
Amortization of debt issuance cost
1,146
1,134
1,158
1,152
Stock-based compensation
11,787
9,895
11,382
7,700
Non-cash lease expense
2,126
2,005
2,299
1,789
Deferred tax
827
1,907
637
-2,963
Change in fair value of contingent consideration liabilities
-5,401
581
5,166
-
Other
-4,171
-2,564
-7,268
1,051
Receivables, net
-
-
9,424
-
Other receivables
-
-
-2,261
-
Prepaid expenses and other current assets
-
-
-4,718
-
Other assets
-
-
-3,505
-
Accounts payable and accrued expenses
-
-
-6,994
-
Fiduciary accounts payable
-
-
-4,699
-
Medical liabilities
-
-
8,890
-
Income taxes payable/receivable
-
-
5,326
-
Operating lease liabilities
-
-
-6,049
-
Other liabilities
-
-
-632
-
Changes in operating assets and liabilities, net of business combinations
-7,567
-9,637
-
-15,446
Net cash provided by operating activities
32,748
68,056
-2,886
9,956
Payments for business and assets acquisition, net of cash acquired
3,739
-
51
548,553
Proceeds from sale of equity method investment
-
-
0
15,100
Purchases of investments equity method
-
-
0
0
Purchase of call option issued in conjunction with equity method investment
-
-
0
0
Issuance of loans receivable
-
-
0
658
Purchases of property and equipment
3,878
4,000
3,064
2,552
Other
-1,389
-1,156
-2,058
-2,192
Net cash used in investing activities
-6,228
-2,844
-1,057
-534,471
Dividends paid
95
104
1,556
96
Borrowings on long-term debt
-
-
-
707,300
Borrowings on debt
0
0
1,119,300
-
Repayment of long-term debt
-
-
-
51,966
Repayment of debt
91,966
11,967
495,289
-
Deferred financing cost
0
0
0
1,964
Payment of financing obligation
-
-
0
-
Payment of contingent liabilities
2,864
-
0
8,284
Taxes paid from net share settlement of restricted stock
2,662
1,172
607
509
Repurchase of treasury shares
-100
2,906
15,429
-
Repurchase of subsidiary's shares
1,558
-
-
-
Other
-5,029
189
3,221
4,010
Net cash used in financing activities
-104,074
-15,960
-26,337
648,491
Net (decrease) increase in cash, cash equivalents, and restricted cash
-77,554
49,252
-30,280
123,976
Cash, cash equivalents, and restricted cash, beginning of period
483,297
434,045
464,326
289,102
Cash, cash equivalents, and restricted cash, end of period
405,743
-
-
-
Cash paid for interest
29,348
-
-
-
Right-of-use assets obtained in exchange for operating lease liabilities
2,795
-
-
-
Dividend paid in the form of common stock
0
-
-
-
Cash and cash equivalents
400,792
-
-
-
Restricted cash
4,951
-
-
-
Total cash, cash equivalents, and restricted cash, end of period shown in the statement of cash flows
405,743
483,297
434,045
464,326
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income$18,452K (12.26%↑ Y/Y)Depreciation andamortization$15,549K (13.07%↑ Y/Y)Stock-based compensation$11,787K (-39.61%↓ Y/Y)Non-cash lease expense$2,126K (-16.92%↓ Y/Y)Amortization of debt issuancecost$1,146K (-34.14%↓ Y/Y)Deferred tax$827K (142.17%↑ Y/Y)Net cash provided byoperating activities$32,748K (-69.54%↓ Y/Y)Canceled cashflow$17,139K Net (decrease)increase in cash, cash...-$77,554K (-251.33%↓ Y/Y)Canceled cashflow$32,748K Repurchase of treasuryshares-$100K Other-$1,389K (32.87%↑ Y/Y)Changes in operatingassets and...-$7,567K (-114.67%↓ Y/Y)Change in fair value ofcontingent consideration...-$5,401K Other-$4,171K (-206.68%↓ Y/Y)Net cash used infinancing activities-$104,074K (-97.08%↓ Y/Y)Canceled cashflow$100K Net cash used ininvesting activities-$6,228K (-79.43%↓ Y/Y)Canceled cashflow$1,389K Repayment of debt$91,966K Other-$5,029K (-2.13%↓ Y/Y)Payment of contingentliabilities$2,864K Taxes paid from netshare settlement of...$2,662K (-47.32%↓ Y/Y)Repurchase of subsidiary'sshares$1,558K Dividends paid$95K (-98.48%↓ Y/Y)Purchases of property andequipment$3,878K (-13.63%↓ Y/Y)Payments for business andassets acquisition,...$3,739K

Astrana Health, Inc. (ASTH)

Astrana Health, Inc. (ASTH)